Joseph C. Galante - 08 Jul 2021 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Joseph C. Galante by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
08 Jul 2021
Net transactions value
+$8,005
Form type
4
Filing time
13 Aug 2021, 17:13:46 UTC
Previous filing
11 Jun 2021
Next filing
10 Sep 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $452 +142 +0.44% $3.18 32,559 08 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $444 +142 +0.44% $3.13 32,701 09 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $473 +142 +0.43% $3.33 32,843 12 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $494 +142 +0.43% $3.48 32,985 13 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $473 +142 +0.43% $3.33 33,127 14 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $464 +142 +0.43% $3.27 33,269 15 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $466 +142 +0.43% $3.28 33,411 16 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $459 +142 +0.43% $3.23 33,553 19 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $460 +142 +0.42% $3.24 33,695 20 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $463 +142 +0.42% $3.26 33,837 21 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $477 +142 +0.42% $3.36 33,979 22 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $476 +142 +0.42% $3.35 34,121 23 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $481 +142 +0.42% $3.39 34,263 26 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $481 +142 +0.41% $3.39 34,405 27 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $486 +142 +0.41% $3.42 34,547 28 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $486 +142 +0.41% $3.42 34,689 29 Jul 2021 Direct F1
transaction CPIX Common Stock Purchase $470 +142 +0.41% $3.31 34,831 30 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.